Mandate

Vinge advises EQT Infrastructure and Meine Radiologie / Blikk in connection with the acquisition of Aleris’ radiology business

Vinge advises EQT Infrastructure and its portfolio companies Meine Radiologie Holding GmbH and Blikk Holding GmbH in connection with the acquisition of Aleris’ radiology business.

The acquisition includes the full operation of the business area radiology, with 22 units in Sweden and 14 in Norway as well as teleradiology operations in the Baltics, which together carry out more than 1 million radiology exams annually across a broad range of diagnostic imaging modalities.

The acquisition is subject to approval from applicable competition authorities.

Vinge’s team consisted of partner Daniel Rosvall together with Carl Sander, Elsie Nassar, Clara Sohlberg and Ebba Nyberg (M&A), Sam Fakhraie Ardekani (Commercial Agreements), Benjamin Vafaeian (Banking and Financing), Christoffer Nordin (Regulatory and permits), Ulf Pyk (Real Estate), Tove Lövgren Frisk (Compliance), Gustav Lindgren (Employment), Lisa Hörnqvist and Karolina Fuhrman (IT and GDPR), Jolene Reimerson (Separation), Emma Gustavsson (IPR) and Ellinor Gyllenhammar (Project and VDR Assistant).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026